Viatris Inc. (VTRS)
Health Care1 article
Price chart
Why is VTRS moving today?
+2.4%VTRS is +2.4% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
Viatris Inc. (VTRS) overview
Viatris is a generic and specialty pharmaceutical company.
VTRS is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
Viatris Inc. trades on the NasdaqGS under the ticker symbol VTRS. The most recent market data puts the share price at about $18.66. That is up 2.39% on the session. At that price the company is worth roughly $21.43B.
Over the past 52 weeks, VTRS has traded between $9.92 and $18.67. VTRS also pays a dividend. It yields around 2.57% at the current price.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch VTRS
VTRS is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each VTRS story as it breaks, and tags it bullish, bearish or neutral.
What moves VTRS
- Earnings. VTRS reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from VTRS.
- Sector news. Health Care stocks often move together, so a rival's news can move VTRS too.
Market Mood
Latest VTRS news
IHE vs IXJ: 39.7% vs 10% 1-Year Returns in ETFs Comparison
The iShares U.S. Pharmaceuticals ETF (IHE) has posted a 1-year return of 39.70% as of May 20, 2026, while the iShares Global Healthcare ETF (IXJ) reported a return of 10.00%. Both funds have similar expense ratios, with IHE at 0.38% and IXJ at 0.40%. IHE's assets under management (AUM) stand at $883.6 million, compared to IXJ's $3.6 billion. Additionally, IHE has a higher dividend yield of 1.70% versus IXJ's 1.50%, indicating potential advantages for investors favoring domestic pharmaceutical exposure.
Read More: IHE vs IXJ: 39.7% vs 10% 1-Year Returns in ETFs ComparisonMore Health Care stocks
Frequently asked questions
Is Viatris Inc. in the S&P 500?
Yes. Viatris Inc. trades as VTRS and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is VTRS in?
VTRS sits in the Health Care sector of the S&P 500.
Where can I find the latest VTRS news?
Right here. This page collects recent VTRS news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is Viatris Inc.'s stock price?
VTRS last traded at about $18.66. Prices move all through the session, so this is the latest quote rather than a live one.
What is Viatris Inc.'s market cap?
VTRS is worth roughly $21.43B. Market cap is the share price times the number of shares outstanding.